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Purpose and setting: Despite the label “generic” health state utility instruments (HSUIs), empirical evidence
shows that different HSUIs generate different estimates of Health-Related Quality of Life (HRQoL) in the same
person. Once a HSUI is used to generate a QALY, the difference between HSUIs is often ignored, and decision-
makers act as if ‘a QALY is a QALY is a QALY’. Complementing evidence that different generic HSUIs produce
different empirical values, this study addresses an important gap by exploring how HSUIs differ, and processes
that produced this difference. 15 developers of six generic HSUIs used for estimating the QOL component of
QALYs: Quality of Well-Being (QWB) scale; 15 Dimension instrument (15D); Health Utilities Index (HUI);
EuroQol EQ-5D; Short Form-6 Dimension (SF-6D), and the Assessment of Quality of Life (AQoL) were inter-
viewed in 2012–2013.
Principal findings: We identified key factors involved in shaping each instrument, and the rationale for simila-
rities and differences across measures. While HSUIs have a common purpose, they are distinctly discrete con-
structs. Developers recalled complex developmental processes, grounded in unique histories, and these back-
grounds help to explain different pathways taken at key decision points during the HSUI development. The basis
for the HSUIs was commonly not equivalent conceptually: differently valued concepts and goals drove instru-
ment design and development, according to each HSUI's defined purpose. Developers drew from different
sources of knowledge to develop their measure depending on their conceptualisation of HRQoL.
Major conclusions/contribution to knowledge: We generated and analysed first-hand accounts of the development
of the HSUIs to provide insight, beyond face value, about how and why such instruments differ. Findings en-
hance our understanding of why the six instruments developed the way they did, from the perspective of key
developers of those instruments. Importantly, we provide additional, original explanation for why a QALY is not
a QALY is not a QALY.
Quality Adjusted Life Years (QALYs) are the dominant measure of
health benefit used in economic evaluation to inform health care re-
source allocation decisions. QALYs account for both length of life and
health related quality of life (HRQoL) in a single index. Over the past
four decades, a small number of generic preference-weighted health
state utility instruments (HSUIs; also referred to as multi-dimension
utility instruments) have been developed to measure HRQoL for use in
QALYs.
Health state utility measurement comprises two main elements: (a)
a health state classification system: defining and describing a set of
health states of interest, usually presented as a standardised ques-
tionnaire, and (b) valuation of those health states to generate the
HRQoL weights used to generate QALYs.
Six generic HSUIs are used most widely for estimating the quality of
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life component of QALYs (listed in chronological order of develop-
ment): the Quality of Well-Being (QWB) scale; 15 Dimension instru-
ment (15D); Health Utilities Index (HUI); EuroQol EQ-5D; Short Form-6
Dimension (SF-6D), and the Assessment of Quality of Life (AQoL)
(Drummond et al., 2005). All are examined in this study and described
in detail in Table 1 in the next section. EQ-5D is the most extensively
used HSUI worldwide (Richardson et al., 2014; Brazier et al., 2017a,b).
In practice, funding bodies and academics use a variety of HSUIs to
inform their decisions. Although a small number of health technology
assessment (HTA) bodies have specified which measure should be
used—for example, the National Institute for Health and Care Ex-
cellence (NICE) in the UK has specified the EQ-5D as a preferred
measure—typically HTA bodies will accept measures from any of the
above HSUIs (Longworth and Longson, 2008).
The claimed theoretical advantage of generic HSUIs is their ability
to produce values comparable across all interventions and diseases,
thereby producing a common currency for economic evaluation, in-
cluding for use in HTA (Finch et al., 2018). However although the six
instruments are termed generic and used in economic evaluation as if
they are homogenous, they differ in their constructs, including in
content and size of their descriptive systems; valuation methods; and
populations used to value the health states (Brazier et al., 2017a,b).
Further, as demonstrated in head-to-head empirical comparisons, they
also generate different utility values (Fryback et al., 2010; Hawthorne
et al., 2001).
Many health economists (and others) understand that different
HSUIs will: 1) generate different empirical estimations of HRQoL in the
same person; 2) thus produce a different resulting number of QALYs; 3)
generate, therefore, different ratios in cost utility analyses of the same
intervention; and 4) potentially, result in different funding decisions,
depending on which HSUI is used (Richardson et al., 2016; Brazier
et al., 2017a,b). In practice, however, this difference is often ignored,
and decision-makers act as if ‘a QALY is a QALY is a QALY’ regardless of
the instrument.
In this study we go beyond the recognised fact that the instruments
produce different empirical values, to explore and explain how and why
HSUIs differ. To do this, we generated and analysed unique data fo-
cusing on first-hand accounts of the development of the six HSUIs to
provide insight about the development process, from the perspective of
key developers of those instruments. In particular, this study aims to:
1. Explore factors that influenced the original development of six
HSUIs used to calculate QALYs
2. Explain why HSUIs differ in their production of QALYs, from the
perspective of 15 developers of six HSUIs.
Some instrument developers have published accounts of the devel-
opment of some individual instruments (Torrance et al., 1982; Kaplan
and Anderson, 1988; Sintonen and Pekurinen, 1989; Brooks and Group,
1996; Torrance et al., 1996; Hawthorne et al., 1997; Brazier et al.,
2002; Devlin and Brooks, 2017). Informative analyses of published
literature (e.g (Richardson et al., 2016; Brazier et al., 2017a,b; Finch
et al., 2018) compared the construction and validity base of existing
instruments. Some accounts of the development of particular HSUIs
refer to the use of qualitative methods to help generate descriptive
systems (e.g. (Kaplan et al., 1997; Richardson et al., 2012) but stand-
alone qualitative papers linked to particular HSUIs are generally not
published, with some exceptions (e.g. (Herdman et al., 2011; Keeley
et al., 2013; Stevens, 2017).
This current study is the first to explore development across in-
struments as explained by developers from all 6 generic HSUIs. This
study is also the first to take a qualitative approach across a range of
developers allowing a depth and nuance in analysis including a focus on
the meaning and social value underlying HSUIs, which in our view was
not able to be achieved in previous investigations of these measures.
Understanding each instrument's origins and how and why key
decisions were made throughout their development is expected to help
prospective users to choose which HSUI to use in different contexts,
researchers and policy makers to better understand the data that result
from their use, and those considering developing new HSUIs to learn
from existing examples of instrument development.
The literature has expanded beyond generic measures to condition-
specific measures (e.g., instruments focusing on specific areas outside of
health (e.g. ASCOT for measurement of social outcomes, excluding
health status with a broader focus on quality of life) (Netten et al.,
2012), and the emerging literature on the generation of quality of life
measures more generally, for example including capability measures
such as the ICECAP (Coast et al., 2008) and OxCAP (Lorgelly et al.,
2008; Simon et al., 2013; Coast et al., 2015) measures, and the idea of
‘super QALYs’ such as the well-being adjusted life-year: WELBY, po-
tentially for use across sectors such as social care and public health
(Brazier and Tsuchiya, 2015).
Because our study illuminates the detail of similarities and differ-
ences in processes of instrument development, we expect that our
findings are likely to be useful to these efforts also. In the spirit of ac-
cessibility, including to students, in the next section we provide an
overview of the different measures and concepts before moving on to
describe our methods and results. We conclude with a discussion of our
findings, implications and areas for future research.
1. Background
QALYs provide a measure of health gain that incorporate both
quantity and quality of life. In particular, QALYs are calculated as life
expectancy multiplied by the HRQoL experienced in those years. We
note that while ‘Quality of Life’ encompasses a broad range of factors
that shape an individual's life, including non-health aspects, the concept
of HRQoL has been defined in a number of ways. For example, Brazier
et al. review four definitions used in the literature including: in relation
to an individual's functioning and subjective wellbeing; factors that are
part of an individual's health; aspects of quality of life affected by health
– e.g. by the presence or absence of disease; and the value of health
states, or utilities, which can be used to calculate QALYs (Torrance,
1987; Ebrahim, 1995; Weinstein et al., 1996; Killewo et al., 2010;
Karimi and Brazier, 2016). We use the latter in this paper. The HRQoL
index used to “quality adjust” life years is measured on a cardinal scale
from 0 to 1 where 0 is dead and 1 is full health. So, for example, a
person expected to live for a further 10 years in a health-related quality
of life of 0.8 has 8 QALYs.
HSUIs are used to generate the HRQoL values used to quality adjust
life years to generate QALYs. They focus on the utility associated with
health states alone, rather than the broader economic concept of utility
(Bleichrodt and Quiggin, 2013). Health states are described by a broad
range of dimensions to provide response options that enable re-
spondents to accurately describe their current health state. Examples
include psychological wellbeing, pain, ability, and symptoms. They
should ideally be based on direct patient experience, though many use
clinicians as proxies backed by peer-reviewed literature (Tolley, 2009).
HSUIs differ considerably in the content and size of their descriptive
systems, valuation method applied, population used to value the health
states, and scoring algorithms (See Table 1 supplementary and (Brazier
et al., 2017a,b) for a detailed summary and comparison of the de-
scriptive systems).
For example, for the six HSUIs included in this study, health states
are described in terms of capacity (e.g. HUI), function (EQ-5D), or ac-
tual behaviour and performance (e.g. QWB), and the coverage of
symptoms, mental health, and social health (including consequences for
usual activities, work, and relationships) also varies (Brazier et al.,
2017a,b). Only two dimensions – mobility and pain - are covered by all
instruments.
Several “preference elicitation techniques” are used to value health
states in HSUIs, including visual analogue scales (VAS); time trade off
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(TTO), standard gamble (SG), and discrete choice experiments (DCEs)
(Table 2 supplementary).
The VAS is best described as a psychometric response scale, with
two anchors representing ‘best imaginable’ and ‘worst imaginable’
health. In contrast, TTO and SG derive weights by asking participants to
choose between alternative scenarios (e.g. living longer in an impaired
health state or living in full health for a shorter period; or remaining in
a certain impaired health state or taking a gamble of being in full health
or risking death) (Drummond et al., 2005). In recent times, discrete
choice methods have also been used to value health states. The prac-
ticality of each method depends on its acceptability to respondents
(including length and complexity of the task) and its ability to keep the
respondents' interest (Brazier et al., 2017a,b). Another factor is whether
people can actually understand the concepts that the valuation methods
use. For example, the SG assumes people understand probabilities well
and can handle probability calculations; TTO assumes people can
handle implied trade-offs between length and quality of life. The choice
of method matters because differences in their theoretical grounding
and valuation approach can lead to differences in utility estimates for
the same health states.
2. Methods
2.1. Ethics approval
Ethics approval was obtained for the study (Monash University
Human Research Ethics Committee (MUHREC): project number CF12/
2236–2012001201).
2.2. Approach
We chose a qualitative approach because this best allowed us to
answer our research questions. We were genuinely uncertain what de-
velopers would consider to be important in their explanations of in-
strument development: a qualitative approach allowed us to learn more
by remaining flexible in data collection and analysis. A qualitative
approach also allowed for a more nuanced investigation than other
more quantitative methods would have allowed.
2.3. Participant selection and recruitment
Key researchers responsible for the development and modification
of the six instruments were identified from the literature. We employed
a purposive sampling strategy (Patton, 2002; Given, 2008), with the
goal of recruiting more than one informant per instrument. We did not
approach all developers. Instead we identified potential informants
based on when they had been involved in instrument development (e.g.
whether they were originators of the instrument, or whether they
joined the development team later). We made sure that at least one of
the developers per instrument was one of the original developers and
aimed to recruit participants from initial and subsequent stages of de-
velopment. For EQ-5D, which had a larger development group than
other instruments, we recruited more developers. Potential participants
were approached via email. In accordance with the study's ethics ap-
proval, participants were provided with a participant information
statement which explained what was involved in taking part in the
study including that all results would be presented in a de-identified
form with participant names removed. Participants were told that by
replying to the email to be part of the study and arranging a time for
interview they provided their consent.
2.4. Data collection
A pilot study (Wilson, 2010) provided important insights that
guided the design of the main study and a draft topic guide.
We chose semi-structured individual interviews to give individual
developers maximum freedom to explain their own perspective on their
instrument; we interviewed by telephone because informants were lo-
cated all over the world. The participants were interviewed using a
topic guide, including questions on the instrument's background; aims;
development criteria; descriptive system; preference weights; instru-
ment performance; comparisons with other HSUIs; impact, and future
of the instrument and the field more broadly. Interviews were con-
ducted between November 2012 and August 2013. The average inter-
view length was 54min, ranging from 27 to 89min.
One researcher (JS) conducted the interviews and recorded her re-
flections about each interview in field notes. As a health economist, the
interviewer had a shared understanding of terminology used by parti-
cipants. JS was part of the international health economics community
at the time of data collection; she knew some participants on a pro-
fessional basis only (e.g. via occasional contact at conferences and
seminars). Interviews were audiotaped and transcribed verbatim. The
field notes were discussed by researchers (JS and EL) following each
interview.
2.5. Data analysis
Although the study design did not lend itself to theoretical sam-
pling, we used Charmaz's iteration of grounded theory as an approach
to analyse the qualitative data (Charmaz, 2006). Grounded theory
analysis methods are relatively prescriptive: analysis proceeds in stages,
beginning with line by line coding. This technique forces the analyst to
go beyond surface impressions or themes, paying attention to detail and
action. SMC conducted an initial analysis of three interviews. Early line
by line codes included: quantifying the health of nations, valuing
comprehensiveness, evolving, compromising, and allocating resources.
Memo-writing is another key analytic method for grounded theory:
memos are written about cases (individual informants: these memos
capture what the analyst has learned from this interview) and concepts
(these memos allow cross-case comparison about key concepts). SMC
also wrote detailed memos about the first three interviews as well as a
topline conceptual memo which suggested some directions for the
overall analysis, including that it should code for making sense of the
instrument (including the purpose of the instrument, and comparing
instruments or defending one's own instrument), having goals (what
goals people said they had and what these were), developing the in-
strument (coding for the nature of the development process) and va-
luing different characteristics (to capture differences in what developers
took to be a ‘good’ instrument.
This broad direction for analysis was taken up by KP, who with
support from SMC in consultation with EL continued to use line by line
coding and constant comparison (a grounded theory method of com-
paring data across cases) to systematically sort, compare and categorise
data. The overall aim was to identify similarities, differences, re-
lationships and patterns so as to draw conclusions across all of the in-
terviews (Green and Britten, 1998). KP read and coded transcripts of all
interviews, developing and further refining the analytic categories,
which included ‘defending my instrument’, ‘having goals’, and ‘trading
off’. KP continued to write memos, with a particular focus on how in-
sights from each new interview reinforced or altered the categories and
concepts initiated by SMC. SMC, EL, and KP met frequently throughout
the analysis to discuss and develop emerging concepts, categories, and
their relationships, and to ensure interpretive validity of preliminary
findings. KP and SMC were guided by EL, DP, JS and CD's broader
understanding of the relevant literature. The subheadings in our results
section reflect the central categories under which our coding was
eventually organised, and the text of the paper reflects the thinking
recorded in our analytic memos and discussions.
Illustrative quotes are presented in the following section.
Information provided at the end of each quotation includes an acronym
for the HSUI that the developer worked on, ‘p’ denoting ‘participant’,
and then numbering of the interviewees in the order in which they were
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interviewed (e.g. EQP1, HUIP2).
3. Results
Of the 19 people invited to participate, 15 were interviewed. One
declined due to retirement, one did not agree, and one did not respond
after three reminders. Another agreed to be interviewed, but later was
unavailable due to illness. In many instances all of the developers of a
particular instrument were interviewed. The final sample contained two
participants for each instrument except EQ-5D which had five partici-
pants to reflect the much larger development group for that instrument.
Informants were from a range of disciplines with an interest in instru-
ment development, including health economics, medicine, psycho-
metrics, and health service research. As planned, we interviewed at
least one participant involved in the original development of each in-
strument; other participants were involved in subsequent instrument
development. Interviewees were based in North America, Europe and
Australia and include the majority of global HSUI developers.
We found that while the six HSUIs are being used for the same
common purpose – to deliver data for the construction of QALYs for
economic evaluations – and are ostensibly the same ‘type’ of instru-
ment, in practice they construct HRQoL in heterogeneous ways. The
developer's accounts suggest a range of differences between the in-
struments. This included differences in: 1) sources of knowledge un-
derpinning conceptualisations of health and wellness;; 2) development
(purpose, goals, processes); 3) central qualities that were prioritised
throughout instrument development; 4) selecting valuation techniques;
and 5) contextual factors, including histories, collaborations, funders
and shared values. These contrasts help to explain why different path-
ways were taken at key decision points during the HSUIs' development,
resulting in quite different instruments. Supplementary Tables 3–5
provide some detail about developers' perceptions of their instrument
and its development; these tables are explained in detail in subsequent
sections.
4. Developers drew on different knowledge sources to
conceptualise HRQoL differently
All developers aimed to create an instrument that measured HRQoL.
However, this central variable was conceptualised differently by dif-
ferent teams. HRQoL is, in the words of one developer, a ‘complex la-
tent variable’, difficult to describe, and developers ‘don't even agree on
what the latent variable is’ (QWBP2).
These are all different concepts of what it is we think we want to
measure. So it's a bit … I suppose we might call almost normative
element first of all which is about what is it policy makers want to
measure (SFP2).
There is no accepted theory of HRQoL or health that would tell us
what dimensions to include … by the WHO and things like that,
what the instrument should contain conceptually … how to oper-
ationalise this problem and all the instruments work in different
ways (15DP1).
The conception of each instrument was connected to an explicit
purpose, formulated by individual HSUI developers, teams of devel-
opers, and/or funders (Table 3 supplementary).
The design and development of each instrument generally aligned
with its ostensible purpose, and these were diverse. Some purposes
were instrumental: focused on what the instrument would allow the
user to do (monitor populations, allocate resources), others institu-
tional: connected to health care system or policy goals (productivity
comparisons, cost-effectiveness), or epistemic: relating to intrinsic
value of the task for the developer (solving methodological puzzles,
quantifying health). Some commitments shifted as the development
progressed (e.g. initially a research task, eventually developed for use in
population health surveys), and these only sometimes formally articu-
lated.
To conceptualise HRQoL, developers relied on widely varying
sources of knowledge, from authoritative lists through to doing original
research from the ground up. Their choices in this regard tended to be
consistent with their purpose for their instrument (Table 3). For in-
stance, some drew from disciplinary or technical sources: QWB devel-
opers were guided by ‘objective’ medically oriented definitions from
medical textbooks and clinical specialists, ‘looking at how clinicians and
epidemiologists asked about health’ (QWBP1), with a focus on symptoms.
Some utilised health states described in existing instruments or data-
sets: three HSUIs began with a broad theory of QOL derived from the
1948 World Health Organisation (WHO) definition of health. Others
were guided by exploratory work rather than drawing from existing
conceptualisations, looking at ‘the sorts of things people thought were
important, from their health perspective, what things they value’ (15DP2);
‘the attributes … that folks said were the most important’ (HUIP1), and
undertook extensive population surveys. 15D developers drew from
health policy documents to find out how health was conceptualised
(e.g. ability to work). Each essentially constructed a unique classifica-
tion system, reflecting the complexity and nuance of defining and de-
scribing HRQoL, the focus of measurement.
We also identified considerable variation in the processes by which
health states were subsequently constructed and validated, both more
or less formally, including via expert consensus between developers
(‘thrashing it out and finally agreeing’ (EQP4)), empirical engagement
(e.g. with clinicians, psychiatrists, patient groups), or using extensive
statistical analyses. These technical and conceptual commitments, once
secured, tended to be handed down in the culture of an instrument-
development team, whether or not individual developers had a strong
commitment to them.
5. Purpose, central concepts and development processes were
connected
Although a range of commitments and circumstances drove devel-
opment of each HSUI, we were able to observe a central defining
concept at the heart of each HSUI's development (Table 4 supplemen-
tary) . This was our interpretation of the most central ideas that de-
velopers said guided the work, and which they used to explain decisions
and actions taken. In doing this we are not suggesting that each de-
veloper cared about only one thing: rather, we sought to draw out the
most important explanation for why things went the way they did for
each HSUI. These concepts interacted to some extent with the stated
purpose for the instrument, as discussed above.
5.1. An important contrast: Grand goals and purposeful process, or modest
goals and opportunistic process
Some developers recalled broad and ambitious goals for their HSUI,
seemingly driven by public health bureaucracies and public policy. We
observed that these developers referred to, and valued, doing a ‘proper’
job, that is, progressing in a serious way, with intention, systematically.
Other developers described modest, discrete goals for their HSUI - to fill
a perceived need, to incorporate methodological advancements, or to
pursue academic interests. We observed that these developers described
an informal, opportunistic process, with somewhat unexpected out-
comes. Use of EQ-5D and HUI, for example, went greatly beyond their
intended application and ‘accidently’ became stand-alone HSUIs.
Instruments are classified using this distinction in Column 2, Table 4,
and we provide examples in the section following. We note that this
contrast was not absolute: there was a small amount of overlap between
modest and opportunistic goals and grand and purposeful goals for
some instruments (e.g. SF-6D). However, overall, the contrast was
strong and was an important way of distinguishing different HSUI de-
velopment processes.
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HSUIs with grand goals progressed according to clearly defined
institutional objectives and were influenced by the priorities of the
respective health care systems. They were mostly large, funded projects
(e.g. funded by government) with specific requirements evident from
the outset. Scientific foundations, objectivity in design, and/or fol-
lowing the prescriptions of psychometric theory were of primary im-
portance for developers of these HSUIs, which included AQoL, 15D, and
QWB. The central driving concepts of instruments with a population-
level focus tended to correspond with high expectations for the HSUI
itself and the endpoints it could achieve (Table 4). For example,
QWBP1's focus for the QWB was Solving grand problems of measurement
and monitoring of population health, to demonstrate its superiority as a
HSUI. 15DP1's account similarly indicated a mission of Developing the
best (15DP1) instrument on the market, claiming that existing HSUIs
were of poor quality. The AQoL was developed in response to perceived
inadequacies of existing measures but with the core aim of Starting from
scratch, correctly: AQoLP1 described his intention to change habitual
approaches to HSUI development by setting a new gold standard in-
corporating methodological advancements and following prescriptions
of correct psychometric theory. Developers of these instruments mostly
described the impact of their HSUI in the context of national policy
impact, clinical trial relevance, incorporation in population health
surveys, and widespread use in economic evaluation (see Instrument
Impact column in Table 4).
HSUIs with more modest stated purposes began as small-scale,
personal interest projects. They had individually defined goals, gen-
erally confined to the research task at hand; for example, to find a
common set of questions, to modify an existing health state measure, or
to construct a meaningful measure for critical populations. They then
‘accidently’ became stand-alone HSUIs or progressed to a scale that
wasn't really fully anticipated (HUIP2). Exploratory work and consensus-
based decisions were central to the accounts of those developers with
more modest goals, which included EQ-5D, HUI, and SF-6D. Their ac-
counts suggested a focus on the development process, rather than
achieving a specific endpoint. For example, EQP1 described an ex-
ploratory intellectual project of Joining forces (column 3) underlying the
development of the EQ-5D, a joining of researchers across different
disciplines and different countries. Most decision points for the EQ-5D
were described as a collaborative process involving international in-
terdisciplinary teams joining to solve a problem (how to measure
health): ‘it was not really a group to develop something; it was just a
common interest to see what we could do together’ (EQP1). A participant
involved in the development of the SF-6D, which originated from a
doctoral thesis, described development meetings where ‘it was literally a
case where we would sit in Boston having a meeting and we'd go, “Well I
don't know, I'm not sure if you really need that dimension” … she'd go away
(and) a team of researchers somewhere in the building, just running loads of
factor analysis and Rasch analysis, to see how we could reduce the instru-
ment down and it was quite fun … It was really amazing (SFP1).
Developers of (initially) small-scale HSUIs were also particularly
attentive to capturing and reflecting social preferences. For example,
the HUI was developed in the context of illness and Reflecting lived ex-
perience was critical to its developers; HUIP1 reported working em-
pirically with regular people close to illness experiences to ensure de-
scriptive items captured lived conditions. The impact of modest-goal
HSUIs was framed in terms of their practical use (e.g. NICE re-
commended, practice evaluation), broad acceptability (straightforward
and easy to use), contributing to awareness and debates about health
valuation (i.e. it's ‘approachable’), number of translations inter-
nationally, generation of revenue for research purposes, or with re-
ference to intrinsic value, including helping decision makers (Table 4
Instrument Impact column).
Developers who referred to having followed a ‘proper’ prescribed
formula for their HSUI argued that developing a HSUI ‘properly’ in-
volved far less discretion than alternatives and ultimately produced a
more valid and reliable instrument. Unsurprisingly, the ‘proper process’
group and the ‘opportunistic’ group had very different views of whether
‘opportunistic’ instrument construction was acceptable. HUI devel-
opers, who described devising their (opportunistic) classification
system as a ‘cognitive exercise … filling out a space, a hypothesis space
around what we thought the best way would be to represent health’ (HUIP2),
were criticised for ‘forcing the data to fit a strict model’ which some
perceived was not valid (SFP1). With respect to (also opportunistic) EQ-
5D, one developer suggested:
(my impression) … was very strongly, that those guys sat in a room
and just decided which they thought were the best items to include
and did no analysis whatsoever to look at whether they had the right
type of coverage of items … (AQoLP2).
In contradiction to this, an EQ-5D developer asserted:
It wasn't completely just a bunch of people sitting down in a room
and coming up with their own ideas about what the domains ought
to be. I know that there's sort of an impression that that was the case
but there was very early research done passing around of that lay
concept of health (EQP5).
Funding sources and resource availability enabled or constrained
the ability of some projects to achieve their goals, for example, by
limiting (HUI) or enabling (AQoL) formal valuation studies. Some de-
velopers worked under budgetary or time constraints in producing their
instrument and had limited capacity to improvise beyond the task. For
HUIP2, for example, the core process can be characterised as
Steamrolling ahead, within constraints (Table 4). This process was focused
more on development than evaluation; team members described trying
to ‘be careful as we could from a developmental point of view, in terms of
putting the thing together’ because they knew they did not have the re-
sources to do any empirical testing (HUIP2). On the other hand, EQP5
joined the EQ-5D later and described their focus on Staying ahead of the
game, and ‘continuously refreshing what it’s doing’ which was enabled by
the instrument generating a good stream of revenue/business model: ‘so
that you've continuously got quite a large investment in R&D into the in-
strument and the method and so on’ (EQP5).
6. Diverse ideas about what makes a good HSUI
Each developer valued particular characteristics of their own HSUI
and had different interpretations of what makes a ‘good’ instrument
(and, in turn, a poor instrument) and how quality data should be ob-
tained (Table 5 supplementary).
Understandably, each developer rated the performance of all in-
struments against their own personal conception of a ‘good’ instrument.
These conceptions sometimes changed throughout the development
process and over time. For example, psychometrics might become more
important later in the development processes, or common sense deci-
sions might be used to refine health states, following formal psycho-
metric testing, ‘because … it's not a purely statistical question and you have
to have a common sense approach’ (SFP2). It also meant that we observed
subtle variation in each developer's conceptualisation of validity or
what constituted a valid instrument. For instance, in some cases, va-
lidity was conceptualised as the extent to which an instrument could
reflect the lived experience of particular conditions of health and ill-
ness. For others, it was reflected in an instrument's ability to represent
all possible health states or was contingent on making sense to clin-
icians.
6.1. Comprehensiveness and sensitivity, or simplicity and pragmatism
One important contrast in valued qualities was that between com-
prehensiveness and sensitivity on one hand, or simplicity and prag-
matism on the other. As with the previous contrast we made between
types of goals, this contrast in valued qualities was not absolute: there
was a small amount of overlap between these valued qualities for some
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instruments, but overall the contrast was strong and helped explain the
differences between instruments. Prioritising qualities was in some
cases a finely balanced ‘trade-off’ (QWBP1) for a number of developers,
as reflected in several instances of contrasting valued qualities amongst
developers of the same instrument (Column 1, Table 5).
Comprehensiveness and sensitivity were highly prioritised qualities
for several developers. A comprehensive instrument was character-
istically longer to ensure full coverage of, and sensitivity to, a large
number of health states. For developers who valued comprehensive-
ness, ‘good’ instruments captured the full gamut of quality of life
(AQoLP2) and enabled comprehensive assessment of health state
(versus minimal core coverage). Comprehensive HSUIs were justified as
making it possible to reflect real world complexity, for example, in
measurement of functions and symptoms. Such HSUIs were generally
designed to fulfil population-level bureaucratic aims, thus needing to be
sensitive to nuance in every possible health state to capture population-
level variation, such that ‘every person in the universe can find their own
health state if wishing so’ (15DP1); or ‘it's extremely rare that somebody has
a problem that is not captured in one of those indexes' (QWBP1).
In contrast, other HSUI developers valued simplicity and pragma-
tism: their process prioritised stripping back to basic health states, to
locate a common core for easier valuation, ‘so you either had problems or
you didn't in a way. The minimum needed for the objective’ (EQP1). Some
devised their classification systems with a focus on design features that
ensured simplicity for the user/administrator of the instrument, for
valuation. HUIP1 described their process of ‘explicitly, deliberately lim-
iting the number of attributes we included, to make the cognitive task of
valuing the health space more manageable’ (HUIP1). This matters, one
participant explained, because quality in the data is lost when people
reach their information processing limits. EQP4's focus was Improving
user experience: their aim was to provide a coherent instrument that was
easy to use, ‘both from the point of view of the person that's filling it in and
the point of view of the user, whether they be pharma companies, national
health services, or even individual clinicians' (EQP4).
Developers mindful of simplicity and pragmatism recognised the
value in existing work (‘I think we accepted that all these other instruments
were out there and … they'd probably covered the dimensions that needed to
be in there’ (EQP1); ‘the amount of research that went into develop the SF-
36 … was a really good starting point’ (SFP2) rather than striving for
originality. SF-6D developers described ‘Adding value’ and ‘Applying
common sense’ (Table 4), reflecting this quality. They detailed a process
of working to maximise return on existing effort and available resources
and building on that incrementally. This is in comparison to 15D, for
example, whose developers started new, reasoning that they could not
be sure that existing generic measures would capture the issues of im-
portance to their target population.
Those interviewees that valued simplicity and pragmatism were
‘baffled’ by instruments that set up millions of health states, reasoning
that empirical work demonstrates that fewer than one hundred health
states have been observed in practice. They argued that a large number
of dimensions leads to problems of overlap and confusion for people
valuing the states.
Variation in the developers' perceived indicators of a ‘good’ instru-
ment was particularly evident in how they prioritised and ‘traded-off’
conflicting HSUI criteria in line with their most valued qualities (e.g. a
comprehensive classification system that could be sensitive to the
greatest number of health states with the pragmatism of a short, simple
system with fewer dimensions). But ‘the problem of course is that these
criteria are at least to some extent, conflicting … so you have to somehow
strike a balance between these criteria … a fair balance between these dif-
ferent parts of criteria’ (15DP1). Many participants acknowledged that
favouring one criterion mostly unbalanced or affected others nega-
tively, so they had to make decisions either individually or as a group.
7. Selecting valuation techniques
Commitment to simplicity and pragmatism carried over into peo-
ple's approach to valuation (Table 5 Column 4). Some developers se-
lected their valuation methods with a focus on the user of the instru-
ment – they described prioritising the simplest technique, or the more
understandable method for lay populations. For example, 15DP2, who
emphasised the importance of Designing for ordinary people, said of the
VAS thermometer: ‘everyone can grasp that, everyone can understand what
it means. It's a visual and it is easy to use, it's been applicable, it's easy to
comprehend. Other ways of deriving the values, I think they are much more
difficult for lay people’ (15DP2). Other developers described their stra-
tegies for making their techniques more approachable; for example,
HUIP1 described deliberately building in space for people to think be-
fore they choose.
Doing the VAS first and then the Standard Gamble is a cognitive
process of giving the person some time to think about it and reflect
and then give you their answer on the choice based technique
(HUIP1).
Most development teams made valuation technique decisions early
in the process; sometimes these had been made earlier and became
‘given’ (SFP1) (Table 3). Some conducted or turned to published em-
pirical work comparing different scaling methodologies (e.g. EQ-5D
developers tried person trade-off (PTO) but people didn't understand
it). Other principles employed included following disciplinary tradition
or doing what was ‘fashionable’ or publishable at the time: for example,
the DCE method was described as a ‘modern fad’ (EQP4). Others de-
veloped new methods because existing options could not do what they
needed them to do (e.g. 15D, where there were so many health states to
be valued that existing methods were insufficient). Even within in-
struments there were differing recounts and differences in opinion
across developers; the EQ-5D, a HSUI developed by a relatively large
group of people in different locations, is a good example. One developer
described a process involving a lot of discussion, about which one (tech-
nique) was best and group consensus on an official valuation method,
because now and again, you just have to make decisions like that …
Sometimes we just have to go with the main consensus even if we don't agree
with it … that's the general ethos (EQP1), while another had a contrasting
view and referred to a ‘kerfuffle’ over valuation:
They've (group members) kind of gone off and made their own scientific
decision about it without having worked out a consensus in the EuroQol
Group. I mean it was a bit of a kerfuffle … it was actually a bit controversial
at the time (EQP5).
There was disagreement over the importance of weighting techni-
ques. Not all developers were happy with their valuation systems; some
planned to change these, others did not have the resources to do so.
8. All HSUIs are the product of a host of variables, shaped by their
environment, and thus perform uniquely in different contexts
It is not surprising, given the subtle and consequential decisions that
were made (individually and collectively) throughout each instrument's
development, that they each have their own strengths and capabilities.
There was wide acknowledgement by the developers that the HSUIs
perform uniquely when applied in different contexts, each with their
own strengths and weaknesses. One concluded,
There's no perfect instrument … in many ways, quality of life as-
sessment is in a state of alchemy … and the instruments, I think …
perform remarkably well given how different they are and how si-
milar a result they come up with (QWBP2).
One HSUI may work well in one context (e.g. academic research)
but not another (e.g. clinical practice). Most developers consequently
emphasised that instruments should be selected to best fit with the
goals of the user or to suit specific needs. One HSUI may be more
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important for public health care decision making bodies, another for
clinical studies, an academic research project, or a pharmaceutical
company comparing different things, depending on the outcome of
interest: ‘it is a social question, not a technical or economic question, what it
is we want to measure’ (AQoLP1). However, using different HSUIs in
different situations rather than across all conditions for consistency will
increase validity, but with implications for comparability, ‘It turns out
that maybe things, they're not comparable’ (QWBP1),
If you start using different instruments in different situations, you
know, you'll run into questions about well can you really compare
QALYs generated by different instruments and the answer probably
is, is no but if you don't think one instrument is adequate in all
situations, you're kind of forced to do that in some situations (SFP2).
I do think that the validity of instruments to some extent depends on
condition and that contradicts the fundamental aim of a lot of
economists is that they want one instrument across all groups, so
you have this sort of … it makes a conflict or problem (SFP2).
9. Future instrument development
The developers were invited to provide advice for future researchers
contemplating further development of HSUIs. Here we summarise their
key points.
Most developers said that progress in the field was contingent on
funding. For example, EQ-5D began as an unfunded research group
with no formal organisation but is now in a position to charge a license
fee for commercial use (while being free to academics and the public),
so has capacity for ‘continuously refreshing what it’s doing and staying
ahead of the game’ (EQP5). HUI developers indicated that if funding
were available, they would be interested in examining Item Response
Theory (IRT) and Computer Adaptive Testing (CAT) in relation to in-
strument development.
Some developers emphasised the need to continue to develop
methods and expand disciplinary reference points. One, for example,
said: ‘I think if anybody's literally going to go out there and do this again,
then they would have a much better econometric toolbox’ (SFP1). Others
suggested moving away from econometric traditions and towards psy-
chology in particular, some suggesting economists have been ‘naïve in
the way they thought people process information’ (AQoLP2). This included,
for example, paying attention to criteria in descriptive systems rather
than criteria for utility weights, ‘looking at what psychology has to offer’
to measure traits (AQoLP1) and focusing on psychometrics, specifically
examining the sensitivity of HSUIs to happiness to provide essential
insights to the existing HSUIs:
What should happen is we ought to be looking at what psychologists
have had to offer and asking ourselves the question, “If utility
doesn't correlate with happiness, why?” Is it that we don't want
happiness or is it that there's something wrong with our instrument?
(AQoLP1)
Relatedly, there was some advocacy for increasing the use of qua-
litative research techniques to understand the impact of diagnoses on
people's lives, incorporating social care into the scope of instruments,
developing a children's mental health instrument, encompassing health
and non-health sectors, or to track service use and compare across
conditions and treatment settings.
Perhaps most controversially, one developer - while maintaining
that their team probably made the right choices at the time - had come
to believe that valuation methods used in HSUIs are irreparably flawed.
He therefore rejected the use of HSUI, the calculation of QALYs, and
making policy decisions based on imagined health states, arguing that:
‘I think it's really a serious problem of misallocation, if we base things on
people's misguided representations of what the future would be like’ (EQP5).
10. Discussion
Descriptive and empirical studies demonstrate that ‘generic’ HSUIs
perform differently in head-to-head comparisons and this is widely
acknowledged in the published literature (e.g. (Richardson et al., 2014;
Brazier et al., 2017a,b)). But, in practice, once they are used in the
calculation of QALYs those differences seem to be forgotten or become
less apparent, and the resulting values (0–1) are commonly applied as if
they are homogenous and comparable. That is, one QALY generated
using one HSUI appears to be very much like one QALY generated using
a different HSUI. Ultimately, their generic label conceals the deep
processual, conceptual, and disciplinary differences sitting behind each
HSUI.
Using unique data collected from developers of all the major HSUIs,
we highlight the meaning and social value underlying HSUIs that is
absent in existing quantitative evaluations of these measures. This
analysis captured the challenge and practical realities of developing a
generic instrument, and illuminated the central role of human, nor-
mative judgments in addition to technical considerations. The devel-
opers described a chain of decisions that they or their team made
throughout the development process, guided by distinct explicit or
implicit purposes and personal views of what the HSUI should do or
achieve. Teams of developers made different sets of decisions, such that
the HSUI that underpins each QALY calculation is very different. Our
qualitative findings highlight that the construction of a HSUI does not
follow a preconceived formula: they are developed through complex
human processes driven by differing values. The development of each
HSUI was organised around unique purposes - for example, to measure
children's cancer outcomes (HUI), the health of nations (QWB), or the
effectiveness of hospital interventions (15D) – so they essentially
measure different constructs. We also found differences in approaches
used to define and develop the descriptive system, preference weighting
methods, and diversity in developer perceptions of what qualities make
a good measure, and the depths of those differences were marked.
Participants were key informants with detailed knowledge who
provided in-depth data. We took care to recruit participants from initial
and subsequent stages of development. It is important to note that be-
cause most instruments were developed 20–40 years ago, some parti-
cipants were concerned about their ability to remember accurately and
provide a complete account of all aspects of instrument development.
However, all interviews were extensive and it was striking how pow-
erfully developers remembered the goals and values that underpinned
their work. Given a number of the key developers are retiring, this
study is particularly timely. Our analysis was based only on retro-
spective interviews; although beyond scope for this project, we note
that archival historical research, if documents from development pro-
cesses were available, would complement our analysis. We consider it a
strength of our sampling strategy that we spoke to a large proportion of
living developers, including in some instances all developers of an in-
strument.
In this study, we have delved deeper than psychometrics or statis-
tical properties captured in head-to-head comparisons (which can
show, for example, that instrument choice may have a significant effect
on health state estimates and effect size calculations). Distinctively, we
spoke directly with developers of six HSUIs and have helped to explain
how and why these different ways of producing these HRQoL or utility
weights came to be different.
These findings are important because differences in health state
values derived from different preference-based measurement instru-
ments have been shown to have potentially important implications for
QALY calculations, and in turn implications for public policy and re-
source allocation: the incremental cost per QALY of health care inter-
ventions and hence the cost-effectiveness of interventions. For example,
a health technology can appear more or less cost-effective depending on
the HSUI that is used. Our results help explain possible reasons for
empirical differences in values generated across HSUIs and bring
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further attention to possible differences in resulting QALYs.
Understanding each instrument's origins and how and why key
decisions were made throughout their development is expected to be
useful to a number of stakeholders including researchers contemplating
using a specific HSUI, policy makers/funders, and future developers.
Taking each in turn, our results may help prospective users to choose
which HSUI to use in different contexts. For example, by alignment
between prospective users' research goals and instrument goals, or
based on greater understanding of the sensitivities or perceived
strengths of particular instruments.
Results can also help policy makers and funders to better under-
stand the data that result from the use of HSUIs and provide further
complementary evidence regarding why a QALY is not a QALY. Finally,
this study provides valuable lessons and insights for researchers con-
templating development of a new instruments for use in health eco-
nomics research drawn from interviews with developers with over 40
years' experience in the field. New instruments to which these insights
are likely to be relevant include new disease and age specific HSUIs as
well as those moving beyond HRQoL and QALYs to generate more
encompassing measures of quality of life or wellbeing. This is in re-
cognition of outcomes that matter to individuals and decision makers
beyond health (e.g. socioeconomic status, home circumstances, social
care) that HSUIs do not adequately capture. This is important both
within the health sector and of course when considering resource al-
location across sectors. This highlights the relevance of this study to
inform not only current HSUIs but potentially also future quality of life
and wellbeing instrument development.
11. Conclusion
The often stated assumption that “a QALY is a QALY is a QALY” has
repeatedly been challenged in the literature, most often because of
evidence suggesting the value attached to QALYs can differ based on
the beneficiaries of the QALYs (e.g. 1 QALY generated for treatment of
children might be valued differently by society or HTA committees to 1
QALY generated in treatment for the elderly) – e.g. (Lancsar et al.,
2011; Gu et al., 2015) - but also due to recognition that different HSUIs
produce different HRQoL (or health state) utility values applied in the
calculation of QALYs. In this paper we provide further complementary
evidence against the assumption, by offering new insight into how and
why the differences in HSUIs have come about, and this a new under-
standing of why a QALY is not a QALY is not a QALY.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.socscimed.2019.112560.
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